Spirit Airlines canceled about 100 flights on Friday after pulling some planes out of service for inspections, and the airline expects the disruptions to last several days.

Spirit did not describe the nature of the inspections and did not respond when asked for further information.

By Friday afternoon, Spirit had canceled 11% of its schedule for the day, easily the highest percentage of scrubbed flights among leading U.S. carriers, according to tracking service FlightAware.

“We’ve cancelled a portion of our scheduled flights to perform a necessary inspection of a small section of 25 of our aircraft,” Spirit said in a statement. “The impact to our network is expected to last several days as we complete the inspections and work to return to normal operations.”

The Federal Aviation Administration said it was aware of Spirit's decision to pull the planes from service for a “mandatory maintenance inspection." The FAA did not describe the inspections either, but said it "will ensure that the matter is addressed before the airplanes are returned to service.”

Spirit had 198 planes as of June 30, all of them variants of the Airbus A320 family, according to a company regulatory filing.

The airline told customers to check the status of their flight before going to the airport.

About half of the Spirit cancellations were at Florida’s Orlando International Airport, where Spirit is the second-largest carrier.

Spirit, which is based in Miramar, Florida, has canceled more than 3,600 flights this year, or 1.5% of its schedule. That is lower than the 2% cancellation rate at Frontier Airlines, a similar budget carrier, and rates for JetBlue Airways and United Airlines.

Share:
More In Business
Regeneron Joins Battle Against COVID-19, Releases Stats on New COVID Treatment
The world hit a grim milestone on Monday, with COVID-19 cases surpassing a quarter of a billion worldwide. As cases increase, the fight to beat the virus continues as well, with a number of medical breakthroughs coming out over the last few months in the form of pills from Pfizer and Merck. Regeneron is now the latest company to join the fight, recently releasing new data on a covid antibody cocktail. Professor Peter Pitts, former FDA Associate Commissioner and the founder of the Center for Medicine in the Public Interest breaks down the differences between the 3 treatments and why vaccines are still among the fire line of defense.
Peloton Stock Continues Steep Drop as It Loses More Than $10B in Value
Doug Astrop, managing partner at Exponential Investment Partners, joined Cheddar to discuss Peloton's precipitous price drop, and whether the company can recover as the at-home workout trend tapers off. "They've lowered the prices on their equipment to try to attract a bigger audience because ultimately they're sort of headed to this Apple ecosystem model where they can monetize a loyal customer base," he said. Astrop noted that he believes there is a reality where the in-person gym experience and Peloton's at-home programs can co-exist.
Markets Look to Continue Record Run
Bill Stone, Chief Investment Officer at Glenview Trust Company, joined Wake Up With Cheddar to break down markets headlines ahead of the start of the trading week.
Load More